The U.S. Food and Drug Administration (FDA) says it is still reviewing the safety of abortion pills along with possible changes to the federal rules that govern the drug. The FDA included that information in a status report that it filed in a federal court in Louisiana last week.
In 2022, the U.S. Supreme Court overturned Roe v. Wade. As a result, abortion is prohibited in states like Arkansas except to save the life of the mother, and it is against the law to mail abortion drugs into many states. But under President Biden, the U.S. Food and Drug Administration adopted rules that let abortionists send abortion drugs like mifepristone through the mail. Pro-abortion lawmakers in other states have also enacted “shield laws” to prevent abortionists from being held accountable when they mail abortion drugs into states like Arkansas. All of this has created a dangerous industry of abortion-by-mail both in Arkansas and across the nation.
But the FDA has been pressured into conducting a safety review of the abortion drug mifepristone. Now the FDA says that review won’t be finished until next year.
In a report filed in federal court last Thursday, the FDA said, “FDA is on track to obtain study results by mid-December 2026. FDA will then need to review and evaluate/interpret the results and draft a report. FDA expects to complete that process not later than March 2027.”
The FDA says it is also reviewing the protocols that govern the abortion drug mifepristone. Once these reviews are finished, the FDA says it could change its abortion drug rules.
Abortion drugs like mifepristone are dangerous. These drugs hurt women, and they kill unborn children.
Research from the Ethics and Public Policy Center shows 11% of women experience serious health complications from abortion pills — including sepsis, infection, and life-threatening hemorrhage.
These drugs should not be available at all — much less through the mail without an in-person visit with a doctor.
Our federal government needs to recognize how serious this issue is and protect Americans from these abortion drugs. That is why we hope all pro-lifers will contact their leaders today in Washington today and ask them to reverse the FDA’s mail-order abortion policy. Click or tap here to contact Congress right now.
Articles appearing on this website are written with the aid of Family Council’s researchers and writers.
